Cingulate Inc.

Most recent annual filing: 2026-03-18

Pipeline (1 active programs)

CTx-1301

Undisclosed indication BDD Pharma

Technology platforms

PTR · BDD Pharma

Precision Timed Release — multi-layer oral tablet delivery platform using a proprietary Erosion Barrier Layer (EBL) to achieve precisely timed, sequential drug releases across the day; disease focus: ADHD and anxiety disorders

Precision Timed Release

PTR proprietary drug delivery platform used to develop next-generation pharmaceutical products; disease focus includes ADHD

Biotech Distilled coverage (4)

2026-05-15 UPDATE: Cingulate (CING) - The CMC Shoe Drops 17 Days Before PDUFA
2026-04-05 UPDATE: Cingulate (CING) - Institutional Adult Supervision Enters the Boardroom 🔒 Paid
2026-03-28 UPDATE: Cingulate (CING) - The Dilution Gap Just Became a Chasm 🔒 Paid
2026-03-23 Cingulate (CING) - Scientific Deep Dive on CTx-1301 and Pipeline Products 🔒 Paid

Articles open on Substack. Some deep dives are subscriber-only.